CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 225 of 235 entries

View as:

THERApy De-escalation for TESTicular Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06309745 Org: User:

Start: 06/24/24 End: 10/02/25 Due: 10/02/26

The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels

Phase: N/A Priority: Normal

NCT ID: NCT01075776 Org: User:

Start: 01/31/20 End: 01/31/23 Due: 01/31/24

Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia?

Phase: N/A Priority: Normal

NCT ID: NCT02802722 Org: User:

Start: 02/24/17 End: 12/31/18 Due: 12/31/19

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

Phase: N/A Priority: Normal

NCT ID: NCT03783416 Org: User:

Start: 06/15/20 End: 08/31/25 Due: 08/31/26

Forensic Facial Reconstruction (FFR) From CT Scans

Phase: N/A Priority: Normal

NCT ID: NCT06496334 Org: User:

Start: 05/28/14 End: 04/30/15 Due: 04/30/16

PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT02423603 Org: User:

Start: 05/14/14 End: 06/30/24 Due: 06/30/25

Toxins and Delivery in e-Cigarette Users

Phase: N/A Priority: Normal

NCT ID: NCT01714778 Org: User:

Start: 02/28/13 End: 01/31/14 Due: 01/31/15

Severe Head Injury Brain Analysis

Phase: N/A Priority: Normal

NCT ID: NCT05206760 Org: User:

Start: 07/15/20 End: 05/16/21 Due: 05/16/22

Effect of Implant Surface Material and Topography on Bone Regeneration.

Phase: N/A Priority: Normal

NCT ID: NCT05890469 Org: User:

Start: 12/01/23 End: 01/27/25 Due: 01/27/26

Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections

Phase: N/A Priority: Normal

NCT ID: NCT04579640 Org: User:

Start: 10/27/20 End: 02/28/22 Due: 02/28/23

Oral Cladribine B-cell Study

Phase: N/A Priority: Normal

NCT ID: NCT06415864 Org: User:

Start: 07/01/19 End: 01/31/24 Due: 01/31/25

Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme

Phase: N/A Priority: Normal

NCT ID: NCT06805136 Org: User:

Start: 02/12/25 End: 01/31/26 Due: 01/31/27

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Phase: N/A Priority: Normal

NCT ID: NCT00324298 Org: User:

Start: 07/31/03 End: 03/31/11 Due: 03/31/12

Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma

Phase: N/A Priority: Normal

NCT ID: NCT04671446 Org: User:

Start: 12/10/20 End: 05/05/24 Due: 05/05/25

Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients

Phase: N/A Priority: Normal

NCT ID: NCT03736018 Org: User:

Start: 11/15/18 End: 09/30/23 Due: 09/30/24

Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)

Phase: N/A Priority: Normal

NCT ID: NCT05600062 Org: User:

Start: 08/24/23 End: 06/15/26 Due: 06/15/27

A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression

Phase: N/A Priority: Normal

NCT ID: NCT03103152 Org: User:

Start: 12/31/16 End: 03/31/20 Due: 03/31/21

Screening for Tuberculosis in Pregnancy

Phase: N/A Priority: Normal

NCT ID: NCT04098341 Org: User:

Start: 07/01/19 End: 05/31/23 Due: 05/31/24

Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01714765 Org: User:

Start: 04/30/11 End: 10/31/12 Due: 10/31/13

Early Discharge Pathway Registry

Phase: N/A Priority: Normal

NCT ID: NCT06040528 Org: User:

Start: 11/11/23 End: 12/31/26 Due: 12/31/27

SPM Regulation by Fish Oil Supplements in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT03347006 Org: User:

Start: 03/20/17 End: 06/15/18 Due: 06/15/19

Skin Ageing Signatures and Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03265678 Org: User:

Start: 06/02/17 End: 01/22/18 Due: 01/22/19

Slowing Parkinson's Early Through Exercise Dosage - United Kingdom

Phase: N/A Priority: Normal

NCT ID: NCT06600438 Org: User:

Start: 01/01/25 End: 07/01/29 Due: 07/01/30

Tamoxifen for the Prevention of Breast Cancer in High-Risk Women

Phase: N/A Priority: Normal

NCT ID: NCT00002644 Org: User:

Start: 01/31/94 End: 03/30/11 Due: 03/30/12

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

Phase: N/A Priority: Normal

NCT ID: NCT05208567 Org: User:

Start: 03/14/23 End: 09/02/25 Due: 09/02/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
THERApy De-escalation for TESTicular Cancer	NCT06309745	Queen Mary University of London	user2@example.com	None	2024-06-24	2025-10-02	2026-10-02	-	-	2025-07-14
The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels	NCT01075776	Queen Mary University of London	user2@example.com	None	2020-01-31	2023-01-31	2024-01-31	-	-	2025-07-14
Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia?	NCT02802722	Queen Mary University of London	user2@example.com	None	2017-02-24	2018-12-31	2019-12-31	-	-	2025-07-14
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis	NCT03783416	Queen Mary University of London	user2@example.com	None	2020-06-15	2025-08-31	2026-08-31	-	-	2025-07-14
Forensic Facial Reconstruction (FFR) From CT Scans	NCT06496334	Queen Mary University of London	user2@example.com	None	2014-05-28	2015-04-30	2016-04-30	-	-	2025-07-14
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer	NCT02423603	Queen Mary University of London	user2@example.com	None	2014-05-14	2024-06-30	2025-06-30	-	-	2025-07-14
Toxins and Delivery in e-Cigarette Users	NCT01714778	Queen Mary University of London	user2@example.com	None	2013-02-28	2014-01-31	2015-01-31	-	-	2025-07-14
Severe Head Injury Brain Analysis	NCT05206760	Queen Mary University of London	user2@example.com	None	2020-07-15	2021-05-16	2022-05-16	-	-	2025-07-14
Effect of Implant Surface Material and Topography on Bone Regeneration.	NCT05890469	Queen Mary University of London	user2@example.com	None	2023-12-01	2025-01-27	2026-01-27	-	-	2025-07-14
Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections	NCT04579640	Queen Mary University of London	user2@example.com	None	2020-10-27	2022-02-28	2023-02-28	-	-	2025-07-14
Oral Cladribine B-cell Study	NCT06415864	Queen Mary University of London	user2@example.com	None	2019-07-01	2024-01-31	2025-01-31	-	-	2025-07-14
Establishing Social Connections in Urban Areas: Evaluating a Community-based Programme	NCT06805136	Queen Mary University of London	user2@example.com	None	2025-02-12	2026-01-31	2027-01-31	-	-	2025-07-14
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles	NCT00324298	Queen Mary University of London	user2@example.com	None	2003-07-31	2011-03-31	2012-03-31	-	-	2025-07-14
Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma	NCT04671446	Queen Mary University of London	user2@example.com	None	2020-12-10	2024-05-05	2025-05-05	-	-	2025-07-14
Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients	NCT03736018	Queen Mary University of London	user2@example.com	None	2018-11-15	2023-09-30	2024-09-30	-	-	2025-07-14
Influence of NEP Inhibition on Vascular Leak and Inflammation (NEPi-INFLAMMATION)	NCT05600062	Queen Mary University of London	user2@example.com	None	2023-08-24	2026-06-15	2027-06-15	-	-	2025-07-14
A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression	NCT03103152	Queen Mary University of London	user2@example.com	None	2016-12-31	2020-03-31	2021-03-31	-	-	2025-07-14
Screening for Tuberculosis in Pregnancy	NCT04098341	Queen Mary University of London	user2@example.com	None	2019-07-01	2023-05-31	2024-05-31	-	-	2025-07-14
Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer	NCT01714765	Queen Mary University of London	user2@example.com	None	2011-04-30	2012-10-31	2013-10-31	-	-	2025-07-14
Early Discharge Pathway Registry	NCT06040528	Queen Mary University of London	user2@example.com	None	2023-11-11	2026-12-31	2027-12-31	-	-	2025-07-14
SPM Regulation by Fish Oil Supplements in Healthy Volunteers	NCT03347006	Queen Mary University of London	user2@example.com	None	2017-03-20	2018-06-15	2019-06-15	-	-	2025-07-14
Skin Ageing Signatures and Cancer	NCT03265678	Queen Mary University of London	user2@example.com	None	2017-06-02	2018-01-22	2019-01-22	-	-	2025-07-14
Slowing Parkinson's Early Through Exercise Dosage - United Kingdom	NCT06600438	Queen Mary University of London	user2@example.com	None	2025-01-01	2029-07-01	2030-07-01	-	-	2025-07-14
Tamoxifen for the Prevention of Breast Cancer in High-Risk Women	NCT00002644	Queen Mary University of London	user2@example.com	None	1994-01-31	2011-03-30	2012-03-30	-	-	2025-07-14
London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound	NCT05208567	Queen Mary University of London	user2@example.com	None	2023-03-14	2025-09-02	2026-09-02	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance